Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
2.35
-0.06 (-2.49%)
At close: Oct 17, 2025, 3:59 PM
2.34
-0.43%
After-hours: Oct 17, 2025, 06:46 PM EDT
-2.49% (1D)
| Bid | 2.2 |
| Market Cap | 107.31M |
| Revenue (ttm) | 166K |
| Net Income (ttm) | -5.47M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -9.04 |
| Forward PE | -3.55 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.45 |
| Volume | 61,434 |
| Avg. Volume (20D) | 163,882 |
| Open | 2.42 |
| Previous Close | 2.41 |
| Day's Range | 2.25 - 2.43 |
| 52-Week Range | 1.50 - 2.95 |
| Beta | 1.68 |
| Ex-Dividend Date | n/a |
About ENTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+10.75%
Entera Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
7 months ago
+3.72%
Entera Bio shares are trading higher after entering a collaboration agreement with OPKO Health to advance a GLP-1/Glucagon candidate.
